Skip To Navigation Skip To Content Skip To Footer
    Since we launched the platform, our practice has grown from 48 to 65 FTEs, excluding providers, and we have recaptured profits that were previously going to our vendors. We are now able to provide infusions for other practices in our market and we are already recruiting for another doctor and one to two mid-levels to support this new volume. Additionally, we are looking to convert our CFO to permanent full-time status this year. The ability to track performance, provide feedback, and adjust our business is key to supporting future growth.” 
    - Stacy (Yonker) Atwell, MBA, CMPE, LSSBB, CRCMP, CRMS, Chief Executive Officer of Sarasota Arthritis Center


    How did MGMA Analytics make this happen?

    To improve slim healthcare margins, Sarasota aimed to bring infusions and billing in-house. They chose our Analytics platform for better dashboards and analytics to support the transition and enhance profitability by understanding key performance factors.

    The machine learning capabilities of the platform, known as RevIntel, were a huge differentiator.


    Fill out the form to download the case study and learn more!

    Explore Related Content

    Ask MGMA
    An error has occurred. The page may no longer respond until reloaded. Reload 🗙